What are the side effects of Rasagiline?

During the clinical development of rasagiline (Rasagiline), patients with Parkinson's disease received rasagiline as initial monotherapy and as adjunctive therapy. In monotherapy, the most common adverse reactions included influenza syndrome, arthralgia, depression, and dyspepsia, with the only adverse reaction leading to discontinuation in more than one patient being hallucinations.

In adjuvant therapy, the most common adverse reactions to rasagiline include peripheral edema, falls, arthralgia, cough and insomnia, movement disorders, accidental injuries, weight loss, orthostatic hypotension, vomiting, anorexia, arthralgia, abdominal pain, nausea, constipation, dry mouth, rash, abnormal dreams, falls and tenosynovitis. Adverse reactions that led to discontinuation in more than one patient were nausea and dizziness, diarrhea, weight loss, hallucinations and rash. Adverse reactions to skin and subcutaneous tissue diseases such as melanoma have occurred after marketing,

The original drug of rasagiline has been launched in China and has entered the category of Class B medical insurance. The common name is rasagiline mesylate tablets, and the specifications areThe price of each box of 1mg*14 tablets may be around RMB 600. The price of the Turkish version of rasagiline's original drug, 1mg*30 tablets, per box sold overseas may be around RMB 310 (the price may fluctuate due to exchange rates). There are also generic drugs produced in other countries. The price of a box of 1mg*100 tablets produced by an Indian pharmaceutical factory may be around RMB 240 (the price may fluctuate due to the exchange rate). The pharmaceutical ingredients of generic drugs are basically the same as those of domestic and foreign original drugs. For specific prices and drug information, please consult Yaode Medical Consultants.